Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Gabapentin Enacarbil Market Growth 2022-2028

  • LP 4760239
  • 115 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Gabapentin Enacarbil will have significant change from previous year. According to our (LP Information) latest study, the global Gabapentin Enacarbil market size is USD million in 2022 from USD 1508.5 million in 2021, with a change of % between 2021 and 2022. The global Gabapentin Enacarbil market size will reach USD 1712.1 million in 2028, growing at a CAGR of 1.8% over the analysis period.

The United States Gabapentin Enacarbil market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gabapentin Enacarbil market, reaching US$ million by the year 2028. As for the Europe Gabapentin Enacarbil landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Gabapentin Enacarbil players cover Arbor Pharma, Astellas, GlaxoSmithKline, and Glenmark Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Enacarbil market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Capsule

Tablet

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Post-Herpetic Neuralgia (PHN)

Restless Legs Syndrome (RLS)

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Arbor Pharma

Astellas

GlaxoSmithKline

Glenmark Pharma

Pfizer

Depomed

Teva

Mylan

Novartis

Apotex

Sun Pharmaceutical

Aurobindo Pharma

Intas

Amneal

Marksans Pharma

Alkem

Jiangsu Enhua

Jiangsu Hengrui

Sailike Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gabapentin Enacarbil Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gabapentin Enacarbil by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gabapentin Enacarbil by Country/Region, 2017, 2022 & 2028

2.2 Gabapentin Enacarbil Segment by Type

2.2.1 Capsule

2.2.2 Tablet

2.3 Gabapentin Enacarbil Sales by Type

2.3.1 Global Gabapentin Enacarbil Sales Market Share by Type (2017-2022)

2.3.2 Global Gabapentin Enacarbil Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gabapentin Enacarbil Sale Price by Type (2017-2022)

2.4 Gabapentin Enacarbil Segment by Application

2.4.1 Post-Herpetic Neuralgia (PHN)

2.4.2 Restless Legs Syndrome (RLS)

2.4.3 Others

2.5 Gabapentin Enacarbil Sales by Application

2.5.1 Global Gabapentin Enacarbil Sale Market Share by Application (2017-2022)

2.5.2 Global Gabapentin Enacarbil Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gabapentin Enacarbil Sale Price by Application (2017-2022)

3 Global Gabapentin Enacarbil by Company

3.1 Global Gabapentin Enacarbil Breakdown Data by Company

3.1.1 Global Gabapentin Enacarbil Annual Sales by Company (2020-2022)

3.1.2 Global Gabapentin Enacarbil Sales Market Share by Company (2020-2022)

3.2 Global Gabapentin Enacarbil Annual Revenue by Company (2020-2022)

3.2.1 Global Gabapentin Enacarbil Revenue by Company (2020-2022)

3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Company (2020-2022)

3.3 Global Gabapentin Enacarbil Sale Price by Company

3.4 Key Manufacturers Gabapentin Enacarbil Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gabapentin Enacarbil Product Location Distribution

3.4.2 Players Gabapentin Enacarbil Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gabapentin Enacarbil by Geographic Region

4.1 World Historic Gabapentin Enacarbil Market Size by Geographic Region (2017-2022)

4.1.1 Global Gabapentin Enacarbil Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gabapentin Enacarbil Annual Revenue by Geographic Region

4.2 World Historic Gabapentin Enacarbil Market Size by Country/Region (2017-2022)

4.2.1 Global Gabapentin Enacarbil Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gabapentin Enacarbil Annual Revenue by Country/Region

4.3 Americas Gabapentin Enacarbil Sales Growth

4.4 APAC Gabapentin Enacarbil Sales Growth

4.5 Europe Gabapentin Enacarbil Sales Growth

4.6 Middle East & Africa Gabapentin Enacarbil Sales Growth

5 Americas

5.1 Americas Gabapentin Enacarbil Sales by Country

5.1.1 Americas Gabapentin Enacarbil Sales by Country (2017-2022)

5.1.2 Americas Gabapentin Enacarbil Revenue by Country (2017-2022)

5.2 Americas Gabapentin Enacarbil Sales by Type

5.3 Americas Gabapentin Enacarbil Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gabapentin Enacarbil Sales by Region

6.1.1 APAC Gabapentin Enacarbil Sales by Region (2017-2022)

6.1.2 APAC Gabapentin Enacarbil Revenue by Region (2017-2022)

6.2 APAC Gabapentin Enacarbil Sales by Type

6.3 APAC Gabapentin Enacarbil Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gabapentin Enacarbil by Country

7.1.1 Europe Gabapentin Enacarbil Sales by Country (2017-2022)

7.1.2 Europe Gabapentin Enacarbil Revenue by Country (2017-2022)

7.2 Europe Gabapentin Enacarbil Sales by Type

7.3 Europe Gabapentin Enacarbil Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gabapentin Enacarbil by Country

8.1.1 Middle East & Africa Gabapentin Enacarbil Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gabapentin Enacarbil Revenue by Country (2017-2022)

8.2 Middle East & Africa Gabapentin Enacarbil Sales by Type

8.3 Middle East & Africa Gabapentin Enacarbil Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gabapentin Enacarbil

10.3 Manufacturing Process Analysis of Gabapentin Enacarbil

10.4 Industry Chain Structure of Gabapentin Enacarbil

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gabapentin Enacarbil Distributors

11.3 Gabapentin Enacarbil Customer

12 World Forecast Review for Gabapentin Enacarbil by Geographic Region

12.1 Global Gabapentin Enacarbil Market Size Forecast by Region

12.1.1 Global Gabapentin Enacarbil Forecast by Region (2023-2028)

12.1.2 Global Gabapentin Enacarbil Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gabapentin Enacarbil Forecast by Type

12.7 Global Gabapentin Enacarbil Forecast by Application

13 Key Players Analysis

13.1 Arbor Pharma

13.1.1 Arbor Pharma Company Information

13.1.2 Arbor Pharma Gabapentin Enacarbil Product Offered

13.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Arbor Pharma Main Business Overview

13.1.5 Arbor Pharma Latest Developments

13.2 Astellas

13.2.1 Astellas Company Information

13.2.2 Astellas Gabapentin Enacarbil Product Offered

13.2.3 Astellas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Astellas Main Business Overview

13.2.5 Astellas Latest Developments

13.3 GlaxoSmithKline

13.3.1 GlaxoSmithKline Company Information

13.3.2 GlaxoSmithKline Gabapentin Enacarbil Product Offered

13.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Main Business Overview

13.3.5 GlaxoSmithKline Latest Developments

13.4 Glenmark Pharma

13.4.1 Glenmark Pharma Company Information

13.4.2 Glenmark Pharma Gabapentin Enacarbil Product Offered

13.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Glenmark Pharma Main Business Overview

13.4.5 Glenmark Pharma Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Gabapentin Enacarbil Product Offered

13.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Depomed

13.6.1 Depomed Company Information

13.6.2 Depomed Gabapentin Enacarbil Product Offered

13.6.3 Depomed Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Depomed Main Business Overview

13.6.5 Depomed Latest Developments

13.7 Teva

13.7.1 Teva Company Information

13.7.2 Teva Gabapentin Enacarbil Product Offered

13.7.3 Teva Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Teva Main Business Overview

13.7.5 Teva Latest Developments

13.8 Mylan

13.8.1 Mylan Company Information

13.8.2 Mylan Gabapentin Enacarbil Product Offered

13.8.3 Mylan Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mylan Main Business Overview

13.8.5 Mylan Latest Developments

13.9 Novartis

13.9.1 Novartis Company Information

13.9.2 Novartis Gabapentin Enacarbil Product Offered

13.9.3 Novartis Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis Main Business Overview

13.9.5 Novartis Latest Developments

13.10 Apotex

13.10.1 Apotex Company Information

13.10.2 Apotex Gabapentin Enacarbil Product Offered

13.10.3 Apotex Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Apotex Main Business Overview

13.10.5 Apotex Latest Developments

13.11 Sun Pharmaceutical

13.11.1 Sun Pharmaceutical Company Information

13.11.2 Sun Pharmaceutical Gabapentin Enacarbil Product Offered

13.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sun Pharmaceutical Main Business Overview

13.11.5 Sun Pharmaceutical Latest Developments

13.12 Aurobindo Pharma

13.12.1 Aurobindo Pharma Company Information

13.12.2 Aurobindo Pharma Gabapentin Enacarbil Product Offered

13.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Aurobindo Pharma Main Business Overview

13.12.5 Aurobindo Pharma Latest Developments

13.13 Intas

13.13.1 Intas Company Information

13.13.2 Intas Gabapentin Enacarbil Product Offered

13.13.3 Intas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Intas Main Business Overview

13.13.5 Intas Latest Developments

13.14 Amneal

13.14.1 Amneal Company Information

13.14.2 Amneal Gabapentin Enacarbil Product Offered

13.14.3 Amneal Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Amneal Main Business Overview

13.14.5 Amneal Latest Developments

13.15 Marksans Pharma

13.15.1 Marksans Pharma Company Information

13.15.2 Marksans Pharma Gabapentin Enacarbil Product Offered

13.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Marksans Pharma Main Business Overview

13.15.5 Marksans Pharma Latest Developments

13.16 Alkem

13.16.1 Alkem Company Information

13.16.2 Alkem Gabapentin Enacarbil Product Offered

13.16.3 Alkem Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Alkem Main Business Overview

13.16.5 Alkem Latest Developments

13.17 Jiangsu Enhua

13.17.1 Jiangsu Enhua Company Information

13.17.2 Jiangsu Enhua Gabapentin Enacarbil Product Offered

13.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Jiangsu Enhua Main Business Overview

13.17.5 Jiangsu Enhua Latest Developments

13.18 Jiangsu Hengrui

13.18.1 Jiangsu Hengrui Company Information

13.18.2 Jiangsu Hengrui Gabapentin Enacarbil Product Offered

13.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Jiangsu Hengrui Main Business Overview

13.18.5 Jiangsu Hengrui Latest Developments

13.19 Sailike Pharma

13.19.1 Sailike Pharma Company Information

13.19.2 Sailike Pharma Gabapentin Enacarbil Product Offered

13.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Sailike Pharma Main Business Overview

13.19.5 Sailike Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Gabapentin Enacarbil Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gabapentin Enacarbil Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Capsule

Table 4. Major Players of Tablet

Table 5. Global Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)

Table 6. Global Gabapentin Enacarbil Sales Market Share by Type (2017-2022)

Table 7. Global Gabapentin Enacarbil Revenue by Type (2017-2022) & ($ million)

Table 8. Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2022)

Table 9. Global Gabapentin Enacarbil Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)

Table 11. Global Gabapentin Enacarbil Sales Market Share by Application (2017-2022)

Table 12. Global Gabapentin Enacarbil Revenue by Application (2017-2022)

Table 13. Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2022)

Table 14. Global Gabapentin Enacarbil Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Gabapentin Enacarbil Sales by Company (2020-2022) & (K Units)

Table 16. Global Gabapentin Enacarbil Sales Market Share by Company (2020-2022)

Table 17. Global Gabapentin Enacarbil Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Gabapentin Enacarbil Revenue Market Share by Company (2020-2022)

Table 19. Global Gabapentin Enacarbil Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Gabapentin Enacarbil Producing Area Distribution and Sales Area

Table 21. Players Gabapentin Enacarbil Products Offered

Table 22. Gabapentin Enacarbil Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Gabapentin Enacarbil Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Gabapentin Enacarbil Sales Market Share Geographic Region (2017-2022)

Table 27. Global Gabapentin Enacarbil Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Gabapentin Enacarbil Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Gabapentin Enacarbil Sales Market Share by Country/Region (2017-2022)

Table 31. Global Gabapentin Enacarbil Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Gabapentin Enacarbil Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)

Table 34. Americas Gabapentin Enacarbil Sales Market Share by Country (2017-2022)

Table 35. Americas Gabapentin Enacarbil Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Gabapentin Enacarbil Revenue Market Share by Country (2017-2022)

Table 37. Americas Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)

Table 38. Americas Gabapentin Enacarbil Sales Market Share by Type (2017-2022)

Table 39. Americas Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)

Table 40. Americas Gabapentin Enacarbil Sales Market Share by Application (2017-2022)

Table 41. APAC Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units)

Table 42. APAC Gabapentin Enacarbil Sales Market Share by Region (2017-2022)

Table 43. APAC Gabapentin Enacarbil Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Gabapentin Enacarbil Revenue Market Share by Region (2017-2022)

Table 45. APAC Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)

Table 46. APAC Gabapentin Enacarbil Sales Market Share by Type (2017-2022)

Table 47. APAC Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)

Table 48. APAC Gabapentin Enacarbil Sales Market Share by Application (2017-2022)

Table 49. Europe Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)

Table 50. Europe Gabapentin Enacarbil Sales Market Share by Country (2017-2022)

Table 51. Europe Gabapentin Enacarbil Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Gabapentin Enacarbil Revenue Market Share by Country (2017-2022)

Table 53. Europe Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)

Table 54. Europe Gabapentin Enacarbil Sales Market Share by Type (2017-2022)

Table 55. Europe Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)

Table 56. Europe Gabapentin Enacarbil Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Gabapentin Enacarbil Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Gabapentin Enacarbil

Table 66. Key Market Challenges & Risks of Gabapentin Enacarbil

Table 67. Key Industry Trends of Gabapentin Enacarbil

Table 68. Gabapentin Enacarbil Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Gabapentin Enacarbil Distributors List

Table 71. Gabapentin Enacarbil Customer List

Table 72. Global Gabapentin Enacarbil Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Gabapentin Enacarbil Sales Market Forecast by Region

Table 74. Global Gabapentin Enacarbil Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Gabapentin Enacarbil Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Gabapentin Enacarbil Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Gabapentin Enacarbil Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Gabapentin Enacarbil Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Gabapentin Enacarbil Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Gabapentin Enacarbil Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Gabapentin Enacarbil Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Gabapentin Enacarbil Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Gabapentin Enacarbil Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Gabapentin Enacarbil Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Gabapentin Enacarbil Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Gabapentin Enacarbil Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Gabapentin Enacarbil Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Gabapentin Enacarbil Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Gabapentin Enacarbil Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Gabapentin Enacarbil Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Gabapentin Enacarbil Revenue Market Share Forecast by Application (2023-2028)

Table 92. Arbor Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 93. Arbor Pharma Gabapentin Enacarbil Product Offered

Table 94. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Arbor Pharma Main Business

Table 96. Arbor Pharma Latest Developments

Table 97. Astellas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 98. Astellas Gabapentin Enacarbil Product Offered

Table 99. Astellas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Astellas Main Business

Table 101. Astellas Latest Developments

Table 102. GlaxoSmithKline Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 103. GlaxoSmithKline Gabapentin Enacarbil Product Offered

Table 104. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. GlaxoSmithKline Main Business

Table 106. GlaxoSmithKline Latest Developments

Table 107. Glenmark Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 108. Glenmark Pharma Gabapentin Enacarbil Product Offered

Table 109. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Glenmark Pharma Main Business

Table 111. Glenmark Pharma Latest Developments

Table 112. Pfizer Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 113. Pfizer Gabapentin Enacarbil Product Offered

Table 114. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Pfizer Main Business

Table 116. Pfizer Latest Developments

Table 117. Depomed Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 118. Depomed Gabapentin Enacarbil Product Offered

Table 119. Depomed Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Depomed Main Business

Table 121. Depomed Latest Developments

Table 122. Teva Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 123. Teva Gabapentin Enacarbil Product Offered

Table 124. Teva Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Teva Main Business

Table 126. Teva Latest Developments

Table 127. Mylan Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 128. Mylan Gabapentin Enacarbil Product Offered

Table 129. Mylan Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Mylan Main Business

Table 131. Mylan Latest Developments

Table 132. Novartis Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 133. Novartis Gabapentin Enacarbil Product Offered

Table 134. Novartis Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Novartis Main Business

Table 136. Novartis Latest Developments

Table 137. Apotex Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 138. Apotex Gabapentin Enacarbil Product Offered

Table 139. Apotex Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Apotex Main Business

Table 141. Apotex Latest Developments

Table 142. Sun Pharmaceutical Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 143. Sun Pharmaceutical Gabapentin Enacarbil Product Offered

Table 144. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Sun Pharmaceutical Main Business

Table 146. Sun Pharmaceutical Latest Developments

Table 147. Aurobindo Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 148. Aurobindo Pharma Gabapentin Enacarbil Product Offered

Table 149. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Aurobindo Pharma Main Business

Table 151. Aurobindo Pharma Latest Developments

Table 152. Intas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 153. Intas Gabapentin Enacarbil Product Offered

Table 154. Intas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Intas Main Business

Table 156. Intas Latest Developments

Table 157. Amneal Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 158. Amneal Gabapentin Enacarbil Product Offered

Table 159. Amneal Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Amneal Main Business

Table 161. Amneal Latest Developments

Table 162. Marksans Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 163. Marksans Pharma Gabapentin Enacarbil Product Offered

Table 164. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Marksans Pharma Main Business

Table 166. Marksans Pharma Latest Developments

Table 167. Alkem Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 168. Alkem Gabapentin Enacarbil Product Offered

Table 169. Alkem Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. Alkem Main Business

Table 171. Alkem Latest Developments

Table 172. Jiangsu Enhua Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 173. Jiangsu Enhua Gabapentin Enacarbil Product Offered

Table 174. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Jiangsu Enhua Main Business

Table 176. Jiangsu Enhua Latest Developments

Table 177. Jiangsu Hengrui Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 178. Jiangsu Hengrui Gabapentin Enacarbil Product Offered

Table 179. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Jiangsu Hengrui Main Business

Table 181. Jiangsu Hengrui Latest Developments

Table 182. Sailike Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 183. Sailike Pharma Gabapentin Enacarbil Product Offered

Table 184. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Sailike Pharma Main Business

Table 186. Sailike Pharma Latest Developments

List of Figures

Figure 1. Picture of Gabapentin Enacarbil

Figure 2. Gabapentin Enacarbil Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gabapentin Enacarbil Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Gabapentin Enacarbil Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gabapentin Enacarbil Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Capsule

Figure 10. Product Picture of Tablet

Figure 11. Global Gabapentin Enacarbil Sales Market Share by Type in 2021

Figure 12. Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2022)

Figure 13. Gabapentin Enacarbil Consumed in Post-Herpetic Neuralgia (PHN)

Figure 14. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2017-2022) & (K Units)

Figure 15. Gabapentin Enacarbil Consumed in Restless Legs Syndrome (RLS)

Figure 16. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2017-2022) & (K Units)

Figure 17. Gabapentin Enacarbil Consumed in Others

Figure 18. Global Gabapentin Enacarbil Market: Others (2017-2022) & (K Units)

Figure 19. Global Gabapentin Enacarbil Sales Market Share by Application (2017-2022)

Figure 20. Global Gabapentin Enacarbil Revenue Market Share by Application in 2021

Figure 21. Gabapentin Enacarbil Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Gabapentin Enacarbil Revenue Market Share by Company in 2021

Figure 23. Global Gabapentin Enacarbil Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region in 2021

Figure 25. Global Gabapentin Enacarbil Sales Market Share by Region (2017-2022)

Figure 26. Global Gabapentin Enacarbil Revenue Market Share by Country/Region in 2021

Figure 27. Americas Gabapentin Enacarbil Sales 2017-2022 (K Units)

Figure 28. Americas Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)

Figure 29. APAC Gabapentin Enacarbil Sales 2017-2022 (K Units)

Figure 30. APAC Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)

Figure 31. Europe Gabapentin Enacarbil Sales 2017-2022 (K Units)

Figure 32. Europe Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Gabapentin Enacarbil Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)

Figure 35. Americas Gabapentin Enacarbil Sales Market Share by Country in 2021

Figure 36. Americas Gabapentin Enacarbil Revenue Market Share by Country in 2021

Figure 37. United States Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Gabapentin Enacarbil Sales Market Share by Region in 2021

Figure 42. APAC Gabapentin Enacarbil Revenue Market Share by Regions in 2021

Figure 43. China Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Gabapentin Enacarbil Sales Market Share by Country in 2021

Figure 50. Europe Gabapentin Enacarbil Revenue Market Share by Country in 2021

Figure 51. Germany Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country in 2021

Figure 58. Egypt Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Gabapentin Enacarbil in 2021

Figure 64. Manufacturing Process Analysis of Gabapentin Enacarbil

Figure 65. Industry Chain Structure of Gabapentin Enacarbil

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390